EPOR Expression Is Independently Associated With Survival in Clear Cell Renal Cell Carcinoma
Anticancer Research · 2026-08 · 46 (8) · 4393-4398
DOI: 10.21873/anticanres.18296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Max Bustillo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, IL, U.S.A.; max.bustillo@ascension.org. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Receptors, Erythropoietin, Kidney Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, IL, U.S.A.; max.bustillo@ascension.org.
- Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, IL, U.S.A.
- Independent Researcher, Chicago, IL, U.S.A.
Zitieren
APA
Bustillo, M., Kakabadze, S., & Palacio, D. (2026). EPOR Expression Is Independently Associated With Survival in Clear Cell Renal Cell Carcinoma. Anticancer Research, 46(8), 4393-4398. https://doi.org/10.21873/anticanres.18296
Vancouver
Bustillo M, Kakabadze S, Palacio D. EPOR Expression Is Independently Associated With Survival in Clear Cell Renal Cell Carcinoma. Anticancer Research. 2026;46(8):4393-4398. doi:10.21873/anticanres.18296
BibTeX
@article{Bustillo2026,
author = {Bustillo, Max and Kakabadze, Sophio and Palacio, Darilis},
title = {EPOR Expression Is Independently Associated With Survival in Clear Cell Renal Cell Carcinoma},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4393--4398},
doi = {10.21873/anticanres.18296}
}
EUVIMED